Lifecore Biomedical, Inc. \De\ Q2 FY2022 Earnings Call

Lifecore Biomedical, Inc. \De\ (LFCR)

Earnings Call FY2022 Q2 Call date: 2022-01-05 Concluded

Quarter scorecard

Revenue

$25.60M

+7.6% YoY

Diluted EPS

$-1.31

Gross margin

44.8%

-0.5 pp YoY

Net income

-$38.47M

Canada $2.90M

-78.8%

Switzerland $2.00M

+185.7%

All Other Countries $900,000

+0%

Czechia $800,000

-33.3%

Ireland $700,000

+75%

Belgium $0

-100%